☆ 4.8 Letter

More on Omicron Infections in Children

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022

Chiara Sacco et al.

Summary: By April 13, 2022, less than 40% of 5-11-year-olds in Italy had been vaccinated against COVID-19 with BNT162b2 (Pfizer-BioNTech), with vaccine effectiveness in preventing SARS-CoV-2 infection and severe COVID-19 found to be lower in this age group compared to individuals aged 12 years and older. The study also noted a decrease in effectiveness against infection after completion of the current primary vaccination cycle.

LANCET (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

COVID-19 vaccination for children aged 5-11 years

Shamez Ladhani

LANCET (2022)

添加到收藏夹

Letter Medicine, General & Internal

Effects of Vaccination and Previous Infection on Omicron Infections in Children

Dan-Yu Lin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Pediatrics

Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany

Anna-Lisa Sorg et al.

Summary: Although children and adolescents have a lower burden of SARS-CoV-2-associated disease, assessing the risk for severe outcomes among infected children remains difficult due to a high rate of undetected cases. A study found that children aged 5-11 without comorbidities have the lowest risk for COVID-19 and PIMS-TS.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

添加到收藏夹

More on Omicron Infections in Children

相关参考文献

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022

COVID-19 vaccination for children aged 5-11 years

Effects of Vaccination and Previous Infection on Omicron Infections in Children

Risk for severe outcomes of COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany

导出引文

分享论文